Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice

Brain Research

Volumn 1167, Issue 1, 2007, Pages 92-100

  Jinnouchi, Yuko ^a   Yamagishi, Sho ichi ^a   Matsui, Takanori ^a   Takenaka, Katsuhiko ^a   Yoshida, Yumiko ^a   Nakamura, Kazuo ^a   Ueda, Shin ichiro ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain edema; NADPH oxidase; PEDF; Permeability

Indexed keywords

APOCYNIN; MESSENGER RNA; PIGMENT EPITHELIUM DERIVED FACTOR; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 2;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; COLD INJURY; CONTROLLED STUDY; ENZYME INHIBITION; FLK 1 GENE; GENE; GENE EXPRESSION; MALE; MECHANICAL PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKULL; UPREGULATION;

ACETOPHENONES; ANIMALS; ANTIBODIES; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURIES; COLD; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EYE PROTEINS; HYPOTHERMIA, INDUCED; MALE; MICE; NADPH OXIDASE; NERVE GROWTH FACTORS; RAC GTP-BINDING PROTEINS; RNA, MESSENGER; SERPINS; SIGNAL TRANSDUCTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MUS; RATTUS;

EID: 34548125012     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.04.088     Document Type: Article

References (38)

1. Aarabi B., Hesdorffer D.C., Ahn E.S., Aresco C., Scalea T.M., and Eisenberg H.M. Outcome following decompressive craniectomy for malignant swelling due to severe head injury. J. Neurosurg. 104 (2006) 469-479
2. Abid M.R., Kachra Z., Spokes K.C., and Aird W.C. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett. 486 (2000) 252-256
3. Bernatchez P.N., Soker S., and Sirois M.G. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J. Biol. Chem. 274 (1999) 31047-31054
4. Dawson D.W., Volpert O.V., Gillis P., Crawford S.E., Xu H.J., Benedict W., and Bouck N.P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285 (1999) 245-248
5. Duh E.J., Yang H.S., Suzuma I., Miyagi M., Youngman E., Mori K., Katai M., Yan L., Suzuma K., West K., Davarya S., Tong P., Gehlbach P., Pearlman J., Crabb J.W., Aiello L.P., Campochiaro P.A., and Zack D.J. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Vis. Sci. 43 (2002) 821-829
6. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74 (1994) 1141-1148
7. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 494-501
8. Inagaki Y., Yamagishi S., Okamoto T., Takeuchi M., and Amano S. Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation. Diabetologia 46 (2003) 284-287
9. Kappelle L.J., and Van Der Worp H.B. Treatment or prevention of complications of acute ischemic stroke. Curr. Neurol. Neurosci. Rep. 2 (2004) 36-41
10. Kawai N., Kawanishi M., Okada M., Matsumoto Y., and Nagao S. Treatment of cold injury-induced brain edema with a nonspecific matrix metalloproteinase inhibitor MMI270 in rats. J. Neurotrauma 20 (2003) 649-657
11. Kimura R., Nakase H., Tamaki R., and Sakaki T. Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction. Stroke 36 (2005) 1259-1263
12. Kondo T., Hafezi-Moghadam A., Thomas K., Wagner D.D., and Kahn C.R. Mice lacking insulin or insulin-like growth factor 1 receptors in vascular endothelial cells maintain normal blood-brain barrier. Biochem. Biophys. Res. Commun. 317 (2004) 315-320
13. Lafuente J.V., Argandona E.G., and Mitre B. VEGFR-2 expression in brain injury: its distribution related to brain-blood barrier markers. J. Neural Transm. 113 (2006) 487-496
14. Liu H., Ren J.G., Cooper W.L., Hawkins C.E., Cowan M.R., and Tong P.Y. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 6605-6610
15. Morita-Fujimura Y., Fujimura M., Kawase M., and Chan P.H. Early decrease in apurinic/apyrimidinic endonuclease is followed by DNA fragmentation after cold injury-induced brain trauma in mice. Neuroscience 93 (1999) 1465-1473
16. Nag S., Takahashi J.L., and Kilty D.W. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J. Neuropathol. Exp. Neurol. 56 (1997) 912-921
17. Otsuka S., Tamiya T., Ono Y., Michiue H., Kurozumi K., Daido S., Kambara H., Date I., and Ohmoto T. The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J. Neuro-Oncol. 70 (2004) 349-357
18. Oury T.D., Piantadosi C.A., and Crapo J.D. Cold-induced brain edema in mice. Involvement of extracellular superoxide dismutase and nitric oxide. J. Biol. Chem. 268 (1993) 15394-15398
19. Papadopoulos M.C., Saadoun S., Davies D.C., and Bell B.A. Emerging molecular mechanisms of brain tumour oedema. Br. J. Neurosurg. 15 (2001) 101-108
20. Paul R., Angele B., Popp B., Klein M., Riedel E., Pfister H.W., and Koedel U. Differential regulation of blood-brain barrier permeability in brain trauma and pneumococcal meningitis-role of Src kinases. Exp. Neurol. 203 (2007) 158-167
21. Schulz J., Plesnila N., Eriskat J., Stoffel M., Pruneau D., and Baethmann A. LF16-0687, a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats. Acta. Neurochir. Suppl. 76 (2000) 137-139
22. Takenaka K., Yamagishi S., Jinnouchi Y., Nakamura K., Matsui T., and Imaizumi T. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci. 77 (2005) 3231-3241
23. Tombran-Tink J., Chader C.G., and Johnson L.V. PEDF: pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res. 53 (1991) 411-414
24. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc. Res. 71 (2006) 226-235
25. Ushio-Fukai M., Tang Y., Fukai T., Dikalov S.I., Ma Y., Fujimoto M., Quinn M.T., Pagano P.J., Johnson C., and Alexander R.W. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 91 (2002) 1160-1167
26. Van Nieuw Amerongen G.P., and van Hinsbergh V.W. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul. Pharmacol. 39 (2003) 257-272
27. Wang J., Takeuchi K., and Ookawara S. Changes of perivascular macrophages in the process of brain edema induced by cold injury. Acta Neurochir., Suppl. 86 (2003) 281-285
28. Wang Y., Jin K., Mao X.O., Xie L., Banwait S., Marti H.H., and Greenberg D.A. VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration. J. Neurosci. Res. 85 (2007) 740-747
29. Wu H.M., Yuan Y., Zawieja D.C., Tinsley J., and Granger H.J. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am. J. Physiol. 276 (1999) H535-H542
30. Yamagishi S., Fujimori H., Yonekura H., Yamamoto Y., and Yamamoto H. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia 41 (1998) 1435-1441
31. Yamagishi S., Inagaki Y., Okamoto T., Amano S., Koga K., Takeuchi M., and Makita Z. Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human cultured mesangial cells. J. Biol. Chem. 277 (2002) 20309-20315
32. Yamagishi S., Inagaki Y., Amano S., Okamoto T., Takeuchi M., and Makita Z. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end products-induced injury through its antioxidative properties. Biochem. Biophys. Res. Commun. 296 (2002) 877-882
33. Yamagishi S., Abe R., Inagaki Y., Nakamura K., Sugawara H., Inokuma D., Nakamura H., Shimizu T., Takeuchi M., Yoshimura A., Bucala R., Shimizu H., and Imaizumi T. Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling. Am. J. Pathol. 165 (2004) 1865-1874
34. Yamagishi S., Inagaki Y., Nakamura K., Abe R., Shimizu T., Yoshimura A., and Imaizumi T. Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. J. Mol. Cell. Cardiol. 37 (2004) 497-506
35. Yamagishi S., Nakamura K., Ueda S., Kato S., and Imaizumi T. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res. 320 (2005) 437-445
36. Yamagishi S., Nakamura K., Matsui T., Inagaki Y., Takenaka K., Jinnouchi Y., Yoshida Y., Matsuura T., Narama I., Motomiya Y., Takeuchi M., Inoue H., Yoshimura A., Bucala R., and Imaizumi T. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J. Biol. Chem. 281 (2006) 20213-20220
37. Yamagishi S., Adachi H., Abe A., Yashiro T., Enomoto M., Furuki K., Hino A., Jinnouchi Y., Takenaka K., Matsui T., Nakamura K., and Imaizumi T. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J. Clin. Endocrinol. Metab. 91 (2006) 2447-2450
38. Yamagishi S., Nakamura K., Matsui T., Yoshida T., Takeuchi M., and Imaizumi T. Pigment epithelium-derived factor (PEDF) blocks advanced glycation end product (AGE)-induced angiogenesis in vitro. Horm. Metab. Res. 39 (2007) 233-235